Denali Therapeutics Inc. (DNLI) Earnings
|
Expand Research on DNLI
| Next EPS Date | 7/30/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -0.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/26  |
Q226 | N/A | -$0.59 | N/A | N/A | $22.59M | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | -$0.69 | -$0.66 | -$0.03 | N/A | $17.96M | N/A |  | | Details | |
| 3/26/26 |
Q425 | -$0.73 | -$0.75 | +$0.02 | N/A | $6.92M | N/A | | | Details | |
| 3/2/26 |
Q425 | N/A | -$0.75 | N/A | N/A | $6.92M | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | -$0.74 | -$0.75 | +$0.01 | N/A | $1.36M | N/A | | | Details | |
| 11/3/25 |
Q325 | N/A | -$0.75 | N/A | N/A | $1.36M | N/A | N/A | N/A | ||
| 10/30/25 |
Q325 | N/A | -$0.75 | N/A | N/A | $1.36M | N/A | N/A | N/A | ||
| 8/11/25 | Q225 | -$0.72 | -$0.71 | -$0.01 | N/A | $7.47M | N/A | | | Details |
